Galantamine hydrobromide and Amlodipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Galantamine hydrobromide (galantamine hydrobromide) and Amlodipine (amlodipine besylate). Common drug interactions include chronic myeloid leukaemia among females and electrocardiogram qt prolonged among males.

The phase IV clinical study analyzes what interactions people have when they take Galantamine hydrobromide and Amlodipine. It is created by eHealthMe based on reports of 496 people who take the same drugs from the FDA, and is updated regularly.

What is Galantamine hydrobromide?

Galantamine hydrobromide has active ingredients of galantamine hydrobromide. It is often used in dementia. eHealthMe is studying from 2,418 Galantamine hydrobromide users. Check the latest studies of Galantamine hydrobromide.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.



On Jul, 20, 2026

496 people who take Galantamine hydrobromide and Amlodipine together, and have interactions are studied.

Galantamine hydrobromide and Amlodipine drug interactions.

What are the common drug interactions of Galantamine hydrobromide and Amlodipine, by gender? *

Click here to view

What are the common drug interactions of Galantamine hydrobromide and Amlodipine, by age (0-1 to 60+)? *

Click here to view

What are the existing conditions these people have? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Galantamine hydrobromide and Amlodipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Galantamine hydrobromide and Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Galantamine hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Galantamine hydrobromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amlodipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide and amlodipine besylate (the active ingredients of Galantamine hydrobromide and Amlodipine, respectively), and Galantamine hydrobromide and Amlodipine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: